State Street SPDR S&P Pha... (XPH)
NYSEArca: XPH
· リアルタイム株価 · USD
72.45
+2.03 (2.88%)
終値時点： Aug 18, 2026, 3:59 PM
State Street SPDR S&P Pharmaceuticals ETF (XPH) ETF Price, Holdings & Analysis
2.88% (1D)
| 買気配 | 0 |
| 時価総額 | n/a |
| 純資産総額 | 489.39M |
| 基準価額 | 70.50 |
| ベータ | 0.7 |
| EPS（過去12か月） | n/a |
| PER（過去12か月） | 19.15 |
| 発行済口数 | 5.5M |
| 設定日 | Jun 19, 2006 |
| 売気配 | 0 |
| 出来高 | 121,770 |
| 平均出来高（20日） | 95,196 |
| 始値 | 71.10 |
| 前日終値 | 70.42 |
| 日中値幅 | 71.06 - 72.48 |
| 52週の値幅 | 45.80 - 72.49 |
| 組入銘柄 | n/a |
| 経費率 | 0.35% |
XPHについて
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
上位10銘柄 純資産の25.66%
| 名称 | シンボル | 構成比 |
|---|---|---|
| Crinetics Pharmaceut... | CRNX | 3.69% |
| Mbx Biosciences Inc | MBX | 3.22% |
| Ataibeckley Inc | ATAI | 2.88% |
| Definium Therapeutic... | DFTX | 2.84% |
| Amylyx Pharmaceutica... | AMLX | 2.29% |
| Enliven Therapeutics... | ELVN | 2.24% |
| Corcept Therapeutics... | CORT | 2.22% |
| Alumis Inc | ALMS | 2.13% |
| Nuvation Bio Inc Ord... | NUVB | 2.09% |
| Trevi Therapeutics I... | TRVI | 2.06% |
分配金 分配金利回り 0.46%
| 権利落ち日 | 金額 | 支払日 |
|---|---|---|
| Jun 22, 2026 | $0.0590 | n/a |
| Mar 23, 2026 | $0.0610 | n/a |
| Dec 22, 2025 | $0.1130 | n/a |
| Sep 22, 2025 | $0.1030 | n/a |
| Jun 23, 2025 | $0.0960 | n/a |
2ページ中1ページ